Insider Buying: Tivic Health Systems (NASDAQ:TIVC) Director Acquires 10,000 Shares of Stock

Tivic Health Systems, Inc. (NASDAQ:TIVC) Director Sheryle Bolton acquired 10,000 shares of the business’s stock in a transaction dated Wednesday, April 15th. The shares were acquired at an average cost of $1.04 per share, with a total value of $10,400.00. Following the transaction, the director owned 10,000 shares in the company, valued at approximately $10,400. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Tivic Health Systems Stock Performance

Shares of NASDAQ:TIVC traded down $0.13 during midday trading on Monday, hitting $1.13. The company had a trading volume of 35,472 shares, compared to its average volume of 202,873. Tivic Health Systems, Inc. has a 12-month low of $0.72 and a 12-month high of $13.23. The company has a fifty day moving average of $0.91 and a two-hundred day moving average of $1.59. The company has a market cap of $3.25 million, a price-to-earnings ratio of -0.17 and a beta of 1.84. The company has a debt-to-equity ratio of 0.38, a current ratio of 20.13 and a quick ratio of 20.13.

Tivic Health Systems (NASDAQ:TIVC) last released its earnings results on Monday, March 30th. The company reported ($1.03) earnings per share for the quarter, beating the consensus estimate of ($408.00) by $406.97.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Tivic Health Systems in a research note on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Tivic Health Systems has a consensus rating of “Sell”.

Tivic Health Systems Company Profile

Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.

The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.